Comments
Some shareholders of Dr Reddy’s have asked the management to split equity shares.
At the 27th annual general meeting of the Hyderabad-based company held here on Thursday, many investors said share split would help small investors as the stock was trading at a 'high' price.
Addressing the shareholders, Dr K. Anji Reddy, founder-Chairman of the company, said research and development efforts will be stepped up for a ‘greater’ impact on near-term earnings.
Work was in progress on over 20 products including new chemical entities (NCE).
“The foremost in the NCE programme is CETP inhibitor which has recently moved to phase e-trials,” Dr Reddy said.
Mr G.V. Prasad, Chief Executive Officer, said in the present year focus would be on increasing operational efficiencies and creation of new capacities.
“The work on special economic zone project is on. It will be commissioned by end of this year,” he added.
Dr Reddy's net profit increased 25 per cent to Rs 262 crore in the first quarter ended June, 2011.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.